BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Royer DJ, Gurung HR, Jinkins JK, Geltz JJ, Wu JL, Halford WP, Carr DJJ. A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity. J Virol 2016;90:5514-29. [PMID: 27030264 DOI: 10.1128/JVI.00517-16] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Gmyrek GB, Berube AN, Sjoelund VH, Carr DJJ. HSV-1 0∆NLS vaccine elicits a robust B lymphocyte response and preserves vision without HSV-1 glycoprotein M or thymidine kinase recognition. Sci Rep 2022;12:15920. [PMID: 36151255 DOI: 10.1038/s41598-022-20180-0] [Reference Citation Analysis]
2 Yin XT, Baugnon NK, Krishnan R, Potter CA, Yarlagadda S, Keadle TL, Stuart PM. CD137 costimulation is associated with reduced herpetic stromal keratitis and with developing normal CD8+ T cells in trigeminal ganglia. J Gen Virol 2022;103. [PMID: 35766977 DOI: 10.1099/jgv.0.001756] [Reference Citation Analysis]
3 Wang H, Davido DJ, Mostafa HH, Morrison LA. Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication. Viruses 2022;14:869. [DOI: 10.3390/v14050869] [Reference Citation Analysis]
4 Liu X, Acharya D, Krawczyk E, Kangas C, Gack MU, He B. Herpesvirus-mediated stabilization of ICP0 expression neutralizes restriction by TRIM23. Proc Natl Acad Sci U S A 2021;118:e2113060118. [PMID: 34903664 DOI: 10.1073/pnas.2113060118] [Reference Citation Analysis]
5 Nabi R, Lewin AC, Collantes TM, Chouljenko VN, Kousoulas KG. Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration. Front Immunol 2021;12:789454. [PMID: 34868077 DOI: 10.3389/fimmu.2021.789454] [Reference Citation Analysis]
6 Carr DJJ, Berube A, Gershburg E. The Durability of Vaccine Efficacy against Ocular HSV-1 Infection Using ICP0 Mutants 0∆NLS and 0∆RING Is Lost over Time. Pathogens 2021;10:1470. [PMID: 34832625 DOI: 10.3390/pathogens10111470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Carr DJJ, Berube AN, Filiberti A, Gmyrek GB. Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0ΔNLS vaccine against ocular HSV-1 challenge. Vaccine 2021;39:2526-36. [PMID: 33814229 DOI: 10.1016/j.vaccine.2021.03.075] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gmyrek GB, Filiberti A, Montgomery M, Chitrakar A, Royer DJ, Carr DJJ. Herpes Simplex Virus 1 (HSV-1) 0ΔNLS Live-Attenuated Vaccine Protects against Ocular HSV-1 Infection in the Absence of Neutralizing Antibody in HSV-1 gB T Cell Receptor-Specific Transgenic Mice. J Virol 2020;94:e01000-20. [PMID: 32999018 DOI: 10.1128/JVI.01000-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Carr DJJ, Gmyrek GB, Filiberti A, Berube AN, Browne WP, Gudgel BM, Sjoelund VH. Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins. Immunohorizons 2020;4:608-26. [PMID: 33037098 DOI: 10.4049/immunohorizons.2000060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
10 Xu X, Feng X, Wang L, Yi T, Zheng L, Jiang G, Fan S, Liao Y, Feng M, Zhang Y, Li D, Li Q. A HSV1 mutant leads to an attenuated phenotype and induces immunity with a protective effect. PLoS Pathog 2020;16:e1008703. [PMID: 32776994 DOI: 10.1371/journal.ppat.1008703] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Ramsey NLM, Visciano M, Hunte R, Loh LN, Burn Aschner C, Jacobs WR Jr, Herold BC. A Single-Cycle Glycoprotein D Deletion Viral Vaccine Candidate, ΔgD-2, Elicits Polyfunctional Antibodies That Protect against Ocular Herpes Simplex Virus. J Virol 2020;94:e00335-20. [PMID: 32295919 DOI: 10.1128/JVI.00335-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
12 Patel CD, Backes IM, Taylor SA, Jiang Y, Marchant A, Pesola JM, Coen DM, Knipe DM, Ackerman ME, Leib DA. Maternal immunization confers protection against neonatal herpes simplex mortality and behavioral morbidity. Sci Transl Med 2019;11:eaau6039. [PMID: 30971454 DOI: 10.1126/scitranslmed.aau6039] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
13 Naidu SK, Nabi R, Cheemarla NR, Stanfield BA, Rider PJ, Jambunathan N, Chouljenko VN, Carter R, Del Piero F, Langohr I, Kousoulas KG. Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis. PLoS One 2020;15:e0228252. [PMID: 32027675 DOI: 10.1371/journal.pone.0228252] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
14 Hoffman M, Chigbu DI, Crumley BL, Sharma R, Pustylnikov S, Crilley T, Ginwala R, Loonawat R, Joseph J, Sales D, Wilson S, Jain P. Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics. Advanced Concepts in Human Immunology: Prospects for Disease Control 2020. [DOI: 10.1007/978-3-030-33946-3_1] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
15 Royer DJ, Montgomery ML, Carr DJ. Mucosal Regulatory System for Balanced Ocular Immunity. Mucosal Vaccines 2020. [DOI: 10.1016/b978-0-12-811924-2.00017-1] [Reference Citation Analysis]
16 Xu X, He Y, Fan S, Feng M, Jiang G, Wang L, Zhang Y, Liao Y, Li Q. Reducing Viral Inhibition of Host Cellular Apoptosis Strengthens the Immunogenicity and Protective Efficacy of an Attenuated HSV-1 Strain. Virol Sin 2019;34:673-87. [PMID: 31506828 DOI: 10.1007/s12250-019-00156-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Zaynutdinova GC. Мodern Approaches to the Treatment and Prevention of Recurrent of Ophthalmic Herpes. Review. Oftalʹmologiâ 2019;16:12-20. [DOI: 10.18008/1816-5095-2019-1s-12-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Man A, Slevin M, Petcu E, Fraefel C. The Cyclin-Dependent Kinase 5 Inhibitor Peptide Inhibits Herpes Simplex Virus Type 1 Replication. Sci Rep 2019;9:1260. [PMID: 30718749 DOI: 10.1038/s41598-018-37989-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
19 Royer DJ, Hendrix JF, Larabee CM, Reagan AM, Sjoelund VH, Robertson DM, Carr DJJ. Vaccine-induced antibodies target sequestered viral antigens to prevent ocular HSV-1 pathogenesis, preserve vision, and preempt productive neuronal infection. Mucosal Immunol 2019;12:827-39. [PMID: 30670763 DOI: 10.1038/s41385-019-0131-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
20 Davido DJ, Tu EM, Wang H, Korom M, Gazquez Casals A, Reddy PJ, Mostafa HH, Combs B, Haenchen SD, Morrison LA. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. J Virol 2018;92:e01036-18. [PMID: 29950407 DOI: 10.1128/JVI.01036-18] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
21 Stanberry LR. Herpes Simplex Virus Vaccines. Plotkin's Vaccines 2018. [DOI: 10.1016/b978-0-323-35761-6.00028-6] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Richards AL, Sollars PJ, Pitts JD, Stults AM, Heldwein EE, Pickard GE, Smith GA. The pUL37 tegument protein guides alpha-herpesvirus retrograde axonal transport to promote neuroinvasion. PLoS Pathog 2017;13:e1006741. [PMID: 29216315 DOI: 10.1371/journal.ppat.1006741] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 8.0] [Reference Citation Analysis]
23 Royer DJ, Carr DJJ. Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?". J Virol 2017;91:e01464-17. [PMID: 29138328 DOI: 10.1128/JVI.01464-17] [Reference Citation Analysis]
24 Ghiasi H. Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth? J Virol 2017;91:e01421-17. [PMID: 29138327 DOI: 10.1128/JVI.01421-17] [Reference Citation Analysis]
25 Lee DH, Ghiasi H. Reply to "Herpes Simplex Virus 1, Macrophages, and the Cornea". J Virol 2017;91:e01317-17. [PMID: 29030535 DOI: 10.1128/JVI.01317-17] [Reference Citation Analysis]
26 Carr DJJ. Herpes Simplex Virus 1, Macrophages, and the Cornea. J Virol 2017;91:e01267-17. [PMID: 29030534 DOI: 10.1128/JVI.01267-17] [Reference Citation Analysis]
27 Royer DJ, Carr MM, Gurung HR, Halford WP, Carr DJJ. The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa. J Immunol 2017;199:1898-911. [PMID: 28760885 DOI: 10.4049/jimmunol.1700316] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
28 Royer DJ, Carr MM, Chucair-Elliott AJ, Halford WP, Carr DJJ. Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. J Virol 2017;91:e02342-16. [PMID: 28122977 DOI: 10.1128/JVI.02342-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
29 Chucair-Elliott AJ, Carr MM, Carr DJJ. Long-term consequences of topical dexamethasone treatment during acute corneal HSV-1 infection on the immune system. J Leukoc Biol 2017;101:1253-61. [PMID: 28115476 DOI: 10.1189/jlb.4A1116-459R] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]